NIDA has reissued its Program Announcements (PAs) soliciting collaborative research proposals by U.S. investigators working with investigators from other countries. The PAs—International Research Collaboration on Drug Abuse and Addiction—will be in effect until January 8, 2015.
Researchers may choose one of three grant programs in response to these broad calls for innovative research proposals: R01, R21, or R03. Priority funding will be given to projects that are collaboratively funded by an agency of the foreign country. Research priority areas include:
- Seek-test-treat and retain HIV/AIDS interventions
- Abuse of amphetamine-type stimulants, synthetic drugs, or other designer drugs
- Inhalant abuse
- Smoking during pregnancy and the impact of prenatal tobacco exposure and the effects of early exposure to tobacco in young people and adolescents on development of addiction and other diseases and on cognitive development
- Drugged driving
To learn more, visit NIDA International Program Announcements.